April 2023
Grant success gives ‘heart in a dish’ research new life
Dr Shiang (Max) Lim and Dr Jarmon Lees have each been awarded Medical Research Future Fund Grants for their projects to deliver new treatments for the currently untreatable debilitating genetic disease, Friedreich ataxia heart disease.
December 2023
New funding to tackle age-related bone disease
Prof Natalie Sims has been awarded a prestigious NHMRC Investigator Grant to better understand the causes of age-related bone fragility.
December 2023
Anna takes action
Thirteen year old Anna Johnston was motivated to participate in the BANDIT trial because she "doesn't want her grandbabies to go through this".
December 2023
New funding for bright ideas
The NHMRC has awarded SVI researchers more than $7.7 million for research into cancer, liver disease, heart disease and type 2 diabetes.
December 2023
Investigating excellence
Three of SVI's researchers have been awarded prestigious NHMRC Investigator Grants to tackle bone disease, heart disease and rare diseases. These grants are awarded Australia's highest achieving researchers.
SVI donors show their love of science
Six young scientists will be able to pursue new projects in 2023, thanks to the commitment and generosity of SVI’s philanthropic donors who attended the recent For the Love of Science dinner.
October 2022
NHMRC grant awarded to Professor Carl Walkley
Professor Carl Walkley’s research aimed at understanding the role of cellular RNA editing received a $2.3M boost with an Investigator Grant from the National Health and Medical Research Council (NHMRC), announced yesterday by the Federal Minister for Health and Aged Care, Mark Butler.
November 2022
New grants for immune cell and bone research
Two new Australian Research Council grants awarded to SVI scientists will help define why immunity differs from person to person, and why bone strength declines as we age.
September 2022
Cancer Australia takes project to next level
Professor Louise Purton, one of Australia’s leading blood disease researchers, has recently been awarded a Cancer Australia grant to improve therapies for myelodysplastic syndromes (MDS).
September 2022
Funding boost for heart repair research
A two-year grant announced today from the Medical Research Future Fund’s Cardiovascular Health Mission will support a team led by SVI’s Dr Shiang (Max) Lim to develop stem cell-based therapy for people suffering heart attack.
September 2022
Targeting immune cells to treat Alzheimer’s
In the search for new treatments, Professor Michael Parker and his team at SVI have focused on different ways that the power of specialised immune cells in the brain – called microglia – can be harnessed.
July 2022
New Fellowship supports gene editing research
SVI's Dr Astrid Glaser has been awarded the Inaugural Captain Courageous Fellowship, for research focused on developing a new treatment path for the genetic condition, Fanconi Anaemia.
September 2022
Brain study leads to bone discovery
A study led by Monash University has resulted in a new area of scientific inquiry for SVI’s Deputy Director and leading bone biologist, Professor Natalie Sims.
July 2022
Unexpected discovery offers rare disease hope
Scientists at SVI have made a ‘surprising’ new finding that may support improved screening, diagnosis and treatment targets for the rare and fatal genetic condition MMIHS (also known as Berdon Syndrome).
July 2022
mRNA research could be key to type 1 diabetes treatment
A team led by SVI’s Associate Professor Mark Chong, has been awarded a two-year grant from the Victorian Government’s new mRNA Research Acceleration Fund to push forward development of an Australian-first mRNA-based treatment for type 1 diabetes.
July 2022
Testing the quality of a COVID RAT
Rapid antigen testing (RAT) for COVID-19 has quickly become a regular routine for many Australians, as a tool to support our return to schools, workplaces and ‘normal’ life.
June 2022
Funding supports new approach to Alzheimer’s disease
A team led by SVI’s Professor Michael Parker was recently awarded a Faye Williams Innovation Grant from the Dementia Australia Research Foundation, to support testing of a potential new approach to treating Alzheimer’s disease.
June 2022
ACMD forges ahead
Set to open in 2024, the $206 million ACMD facility will foster collaboration and enhance Victoria’s bioengineering research capabilities.
June 2022
Using data to get personal with medicine
Machine learning has in recent years been gaining prominence across a number of domains, and this technology also has strong potential for application in bioinformatics and healthcare. A sub-field of artificial intelligence, machine learning involves ‘teaching’ a computer program to learn from its experience of data, resulting in better recognition of patterns over time.
June 2022
Steps that lessen the pain
New SVI research on lipoedema – a debilitating chronic disease often misdiagnosed as obesity – provides a path to potential drug treatments and development of a diagnostic screening test.